Japan's Eisai receives FDA expanded approval for antiepileptic drug Banzel

Japanese pharmaceutical company Eisai has received expanded approval from the US Food and Drug Administration (FDA) for its antiepileptic drug (AED), Banzel (rufinamide) to treat children and infants.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news